Setting 
My Cart
Toggle Nav
mobile icon
Close
  • Menu
  • Setting

Bioactive Compounds

Items 11251-11260 of 13618

Page
per page
  1. Brivanib (BMS-540215)
    A2597 Brivanib (BMS-540215)
    Target: VEGFR|FGFR|Flk1
    Summary: VEGFR-2 inhibitor,ATP-competitive
      insoluble in H2O; ≥18.5 mg/mL
  2. Canertinib (CI-1033)
    A1845 Canertinib (CI-1033)
    Summary: HER family tyrosine kinase inhibitor
  3. AM1241
    A5827 AM1241
     2 Citation
    Summary: Cannabinoid CB2 receptor agonist,potent and selective
      ≥50.3 mg/mL
  4. PH-797804
    A8308 PH-797804
     1 Citation
    Summary: P38 MAP kinase inhibitor, potent and selective
      ≥23.85 mg/mL
  5. Go 6976
    A8341 Go 6976
    Target: PKC
    Summary: PKCα/PKCβ1 inhibitor
      ≥15.77 mg/mL
  6. Gabapentin
    A8436 Gabapentin
    Summary: GABA enhancer
  7. GSK461364
    A8441 GSK461364
     3 Citation
    Target: PLK
    Summary: Plk1 inhibitor
  8. Istradefylline (KW-6002)
    A8454 Istradefylline (KW-6002)
    Target: Adenosine A2A Receptors
    Summary: Selective A2A receptor antagonist
      insoluble in H2O; insoluble in EtOH; ≥8.78 mg/mL
  9. JTC-801
    A8456 JTC-801
    Target: NOP Receptors
    Summary: KOR-3 (NOP) receptor antagonist
      ≥22.4 mg/mL
  10. Pitavastatin Calcium
    A8504 Pitavastatin Calcium
     1 Citation
    Target: HMG-CoA Reductases
    Summary: Enzyme HMGCR inhibitor
      ≥34.85 mg/mL

Items 11251-11260 of 13618

Page
per page